Hidradenitis suppurativa - Management, comorbidities and monitoring

Aust Fam Physician. 2017;46(8):584-588.

Abstract

Background: Hidradenitis suppurativa (HS) is a chronic inflammatory disease presenting in intertriginous areas. HS is associated with a number of disease-modifying comorbidities, including metabolic syndrome and androgen dysfunction, and smoking.

Objective: This review provides a synopsis of the aetiology and diagnosis of HS, and an overview of management for this often devastating disease.

Discussion: The clinical course and disease severity of HS are variable among patients. HS has profound physical and psychological consequences that affect patients' quality of life. Effective treatment is now a realistic goal, but needs to be combined with treatment of the comorbidities and psyche. Evidence-based management guidelines have been established for the management of this disease. General practitioners play a pivotal role in the holistic treatment of this disease.

Publication types

  • Review

MeSH terms

  • Body Image
  • Comorbidity*
  • Disease Management
  • Hidradenitis Suppurativa / diagnosis*
  • Hidradenitis Suppurativa / physiopathology
  • Hidradenitis Suppurativa / therapy*
  • Humans
  • Quality of Life / psychology*
  • Wound Healing